AMIX

Autonomix Medical Inc

• PUBT·2d ago

  Autonomix net loss widens to $16.7 million in FY26; operating expenses rise 47% to $17.03 million

• Benzinga·05/20 08:31

  Why 8x8 Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket

• Benzinga·05/19 17:06

  12 Health Care Stocks Moving In Tuesday's Intraday Session

• TipRanks·05/19 12:47

  Autonomix granted U.S. patent for transvascular monitoring, treatment systems

• Benzinga·05/19 12:36

  Autonomix Medical Announces USPTO Issues U.S. Patent Titled Systems, Methods, And Devices For Monitoring And Treatment Of Tissues Within And/Or Through A Lumen Wall

• Reuters·05/19 12:33

  AUTONOMIX MEDICAL, INC. GRANTED U.S. PATENT FOR TRANSVASCULAR MONITORING AND TREATMENT SYSTEMS WITH REAL-TIME PROCEDURAL VALIDATION

• PUBT·05/19 12:31

  Autonomix Medical wins US patent for transvascular monitoring, real-time procedural validation system

• PUBT·05/18 12:56

  Autonomix Medical abstracts on pancreatic cancer pain mitigation win EuroPCR 2026 acceptance

• PUBT·05/18 12:45

  Autonomix Medical attends EuroPCR with abstracts on pancreatic cancer pain mitigation

• Reuters·05/18 12:45

  AUTONOMIX MEDICAL ANNOUNCES ABSTRACT ACCEPTANCES AT EUROPCR 2026 SHOWCASING LONG-TERM DATA IN PANCREATIC CANCER PAIN MITIGATION

• PUBT·04/29 12:45

  Autonomix long-term pancreatic cancer pain data accepted for presentation at DDW 2026

• Reuters·04/29 12:45

  AUTONOMIX MEDICAL ANNOUNCES ABSTRACT ACCEPTANCE AT DIGESTIVE DISEASE WEEK 2026 SHOWCASING LONG-TERM DATA IN PANCREATIC CANCER PAIN MITIGATION

• PUBT·04/22 12:42

  Autonomix Medical to present long-term pancreatic cancer pain data at ECIO 2026

• Benzinga·04/22 12:05

  12 Health Care Stocks Moving In Wednesday's Pre-Market Session

• Reuters·04/08 12:47

  Autonomix Medical to present pancreatic cancer pain study at SIR 2026 meeting